Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndromeArginine deprivation therapy for malignant melanomaThe treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesClinical use and applications of histone deacetylase inhibitors in multiple myelomaDifferential pharmacology and clinical utility of empagliflozin in type 2 diabetesPharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infectionsChronic hepatitis C: future treatmentAdministration of supplemental L-tyrosine with phenelzine: a clinical literature reviewExpanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysIncidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomibCarbon monoxide: a critical quantitative analysis and review of the extent and limitations of its second messenger functionImmunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesSkin models for the testing of transdermal drugsLRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectivesPathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathwaysThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersMitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingClinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope - a meta-analysis.Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetesComparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study.An integrated epidemiological and neural net model of the warfarin effect in managed care patients.Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective studyPrediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy.Effect of age and sex on warfarin dosingReducing medication errors in critical care: a multimodal approach.Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project.Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug-drug interaction study.The Parkinson's disease death rate: carbidopa and vitamin B6.Melatonergic drugs in development.Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxabanPazopanib for the treatment of soft-tissue sarcoma.Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms.Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteersBioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers.Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin - a model-based studySevere iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockersPharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin.
P1433
Q24605432-D678AF43-E0C8-47C1-8E33-4C94DEB1698EQ24634269-7F1BB060-F0D4-4B4E-998F-169624F465C2Q26744317-97A27DCC-ABBC-4353-880C-55156ECECC0DQ26745930-51AA5EFA-EB2B-47D6-9D94-3D2E26E45EAAQ26749281-1DEB4822-ABBD-432A-ADB2-144647F08267Q26771180-C3941347-04DD-4D3D-91D3-5873A00736B6Q26824075-573BD681-25E9-41D2-AC27-79D81E4CED78Q26853627-D9515511-6B8A-47E2-9054-D06FED31D6B7Q26861539-A1AF01BC-C1C5-44A2-AC8B-4A994A740C5FQ27014143-A2D0E083-3E99-412C-A5EF-1ED5429ACB15Q27025009-89249B9B-675B-497B-BF14-B210BCBB4657Q27027633-62078E77-2280-4092-A453-D7FE6F7973A6Q27337981-E78FB55D-9D95-4EEC-B57B-6B1F24A9FAB8Q28073063-055A7C8A-F81B-49C3-85CA-1055B021CB03Q28074471-424349A5-156F-4408-B3BD-1E0F34EA07ADQ28078899-FC022B1F-4BE8-4CC3-B274-353FE93ACB6DQ28235168-EB61D139-8AC4-471A-A832-5D35FD46D3C0Q28395641-DDDF04C9-73A8-4199-8DC3-2453774A90A8Q28732683-BDAB79BD-244C-498A-B281-A05A5C3D97E0Q33160911-292AE774-103D-4246-8073-E03246BC3189Q33583540-E1027EE2-C786-4B69-9ECA-8104CBB0164FQ33686633-CEEFF754-37A4-4443-BDA1-03C93A4001E9Q33719250-1D4040B1-7DFE-41EE-8B91-8E94745F255DQ33881123-4F804219-F4C9-4343-AEB8-B7E97F597CEDQ33881389-1FFD86B1-F4E2-491D-8946-EEEA43EF1763Q33921765-514B06DA-4D40-4AA2-ACBB-3C419E954CBFQ34140686-B4B25E48-BE04-464E-B953-983A1372283BQ34145562-59A7ED4C-655B-48D7-80FE-C5904DE13CCCQ34386899-F4194FB2-BD38-4093-90E0-CA637F9C9B49Q34415308-9769FB7D-06B9-4381-B460-716163E6EB08Q34440574-E577F95D-F772-4186-AF6B-F8B44F1F2EA2Q34442603-4059278E-7746-4DB9-9FB4-D02096B4FE16Q34531991-814513DF-E9BB-44B9-85C2-F4EEC4AA202FQ34645938-8EE57649-2372-4EF7-9EFB-28224F3DC2C1Q34646991-6614AABF-0559-4D56-AE2E-4EBAD6D6BDBFQ35017701-AE75C399-E43B-4505-8A6C-AB5AE472099EQ35026103-2EE9D98D-FE62-4B1C-85C5-24F3EC415396Q35081727-3C5B7CEC-9AC8-4BF9-B476-3A09F2108385Q35110915-9A220AE1-5E18-4D6D-A55E-294DCDF9B000Q35535457-DACED800-D3A3-44F9-BB77-01D217846571
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Clinical Pharmacology: Advances and Applications
@ast
Clinical Pharmacology: Advances and Applications
@en
Clinical Pharmacology: Advances and Applications
@es
Clinical Pharmacology: Advances and Applications
@it
Clinical Pharmacology: Advances and Applications
@nl
type
label
Clinical Pharmacology: Advances and Applications
@ast
Clinical Pharmacology: Advances and Applications
@en
Clinical Pharmacology: Advances and Applications
@es
Clinical Pharmacology: Advances and Applications
@it
Clinical Pharmacology: Advances and Applications
@nl
altLabel
Clinical Pharmacology : Advances and Applications
@en
prefLabel
Clinical Pharmacology: Advances and Applications
@ast
Clinical Pharmacology: Advances and Applications
@en
Clinical Pharmacology: Advances and Applications
@es
Clinical Pharmacology: Advances and Applications
@it
Clinical Pharmacology: Advances and Applications
@nl
P31
P243
P3181
P1055
P1058
P1156
19700175093
P1476
Clinical Pharmacology
@en
P1680
Advances and Applications
@en
P236
P243
P3181
P407
P5115
P571
2010-01-01T00:00:00Z